Cargando…

Progression to Metastasis of Solid Cancer

Detalles Bibliográficos
Autores principales:	Zacksenhaus, Eldad, Egan, Sean E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916396/ https://www.ncbi.nlm.nih.gov/pubmed/33578666 http://dx.doi.org/10.3390/cancers13040717

Ejemplares similares

The vulnerability of RB loss in breast cancer: Targeting a void in cell cycle control
por: Knudsen, Erik S., et al.
Publicado: (2018)

A Tumor initiating cell-enriched prognostic signature for HER2(+):ERα(−) breast cancer; rationale, new features, controversies and future directions
por: Liu, Jeff C., et al.
Publicado: (2013)

Stratifying the stratifiers of triple negative breast cancer
por: Wang, Dong-Yu, et al.
Publicado: (2020)

Common and distinct features of mammary tumors driven by Pten-deletion or activating Pik3ca mutation
por: Liu, Jeff C., et al.
Publicado: (2016)

Targeting HER2(+) breast cancer: the TBK1/IKKε axis
por: Jiang, Zhe, et al.
Publicado: (2014)

Elevated PI3K signaling drives multiple Breast Cancer subtypes
por: Adams, Jessica R., et al.
Publicado: (2011)

Thinking (Metastasis) outside the (Primary Tumor) Box
por: Jiang, Zhe, et al.
Publicado: (2023)

Timing is everything: Rb’s choice in islet-cell fate
por: Cai, Erica P, et al.
Publicado: (2014)

High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: Interaction with IQ motif-containing factors
por: Robinson, Tyler JW, et al.
Publicado: (2013)

Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma
por: Jiang, Zhe, et al.
Publicado: (2002)

Rescue of myogenic defects in Rb-deficient cells by inhibition of autophagy or by hypoxia-induced glycolytic shift
por: Ciavarra, Giovanni, et al.
Publicado: (2010)

Methylation data of mouse Rb-deficient pineoblastoma
por: Chung, Philip E.D., et al.
Publicado: (2020)

RB1 Status in Triple Negative Breast Cancer Cells Dictates Response to Radiation Treatment and Selective Therapeutic Drugs
por: Robinson, Tyler J. W., et al.
Publicado: (2013)

Attacking Cancer Progression and Metastasis
por: Hunáková, Ľuba
Publicado: (2023)

Metastasis and Tumor Cell Migration of Solid Tumors
por: Hoeppner, Jens, et al.
Publicado: (2021)

Experimental and Clinical Advances in Counteracting Progression of Solid Cancers
por: Nicolini, Andrea
Publicado: (2023)

The ets transcription factor Fli-1 in development, cancer and disease
por: Li, Youjun, et al.
Publicado: (2014)

Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells
por: Ju, YoungJun, et al.
Publicado: (2021)

CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
por: Shrestha, Mariusz, et al.
Publicado: (2023)

Critical Role of the Rb Family in Myoblast Survival and Fusion
por: Ciavarra, Giovanni, et al.
Publicado: (2011)

Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer
por: Wang, Sharon, et al.
Publicado: (2016)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Progress and Recent Advances in Solid Organ Transplantation
por: Thongprayoon, Charat, et al.
Publicado: (2022)

Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2(+):ERα(-) breast cancer
por: Liu, Jeffrey C., et al.
Publicado: (2017)

Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K
por: Liu, Jeff C, et al.
Publicado: (2014)

Fer and FerT Govern Mitochondrial Susceptibility to Metformin and Hypoxic Stress in Colon and Lung Carcinoma Cells
por: Marciano, Odeya, et al.
Publicado: (2021)

Targeting an MDM2/MYC Axis to Overcome Drug Resistance in Multiple Myeloma
por: Faruq, Omar, et al.
Publicado: (2022)

A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling
por: Wang, Dong-Yu, et al.
Publicado: (2019)

FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression
por: Hu, Jifen, et al.
Publicado: (2023)

Metastasis-associated upregulation of ER-Golgi trafficking kinetics: regulation of cancer progression via the Golgi apparatus
por: Howley, Breege V., et al.
Publicado: (2018)

Solid Cancers and Rheumatoid Arthritis
por: Kalliolias, George D., et al.
Publicado: (2023)

SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
por: Wu, Jian, et al.
Publicado: (2021)

Gastrointestinal Cancer Metastasis
por: Chen, Jin-Lian, et al.
Publicado: (2012)

UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progression
por: Hu, Anling, et al.
Publicado: (2022)

Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling
por: Gao, Jian, et al.
Publicado: (2023)

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
por: Liu, Jeff C., et al.
Publicado: (2018)

Targeting Bone Metastasis in Cancers
por: Bonnelye, Edith, et al.
Publicado: (2021)

Cancer metastasis: issues and challenges
por: Qian, Chao-Nan, et al.
Publicado: (2017)

Cerebral Metastasis of Common Cancers
por: Kros, Johan M., et al.
Publicado: (2020)

Underlying Facets of Cancer Metastasis
por: Tyagi, Abhishek
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fbtvvnqersj42f2uctlbmm4351